Clinical Trial Update: Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Proellex (telapristone acetate) for safety and efficacy in premenopausal women with symptomatic uterine fibroids and anemia; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Uterine Fibroids

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids, Anemia | Phase 3 | Status: TERMINATED | Results posted: 2014-08-21